Hemispherx Biopharma to Host Investor Conference Call On Chronic Fatigue Syndrome NDA Filing

July 15, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PHILADELPHIA, July 15, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an investor conference call and webcast to take place on Thursday, July 17, 2008 at 10:00 AM EDT.

Twitter
LinkedIn
Facebook
Email
Print

Events